Retinoblastoma, an eye cancer primarily affecting infants before the age of five, originates in the retina due to genetic mutations. Detectable and curable, there is a nearly 100% survival rate in high-income countries. However, global survival rates vary, emphasizing the need for awareness and accessibility to treatment. The eye, with its intricate chambers, remains a fascinating window to both the soul and the body.
In this video, Professor Didi Fabian, Ocular Oncologist, senior physician at Sheba’s Goldschleger Eye Institute and Director of Sheba Global Ophthalmology, takes us into the fascinating world of the eye. At Sheba, helping people return to life extends beyond the borders of our country, as we bring world-class healthcare all over the globe.